Anzhi Wei

1.2k total citations
25 papers, 861 citations indexed

About

Anzhi Wei is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Anzhi Wei has authored 25 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Anzhi Wei's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers) and Hemophilia Treatment and Research (9 papers). Anzhi Wei is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers) and Hemophilia Treatment and Research (9 papers). Anzhi Wei collaborates with scholars based in United States, Germany and India. Anzhi Wei's co-authors include James Travis, S. Neumann, Emmanuel A. Meyer, Wolfram Bode, Robert Huber, Harvey Rubin, Barry S. Cooperman, David W. Christianson, Dagmar Ringe and Robert H. Abeles and has published in prestigious journals such as The EMBO Journal, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Anzhi Wei

24 papers receiving 842 citations

Peers

Anzhi Wei

HEMAT

GENET

Chang H. Park United States

Douglas A. Jeffery United States

Vanda Pogačić Switzerland

Chih-Min Kam United States

Chih Min Kam United States

Michael S. Bernatowicz United States

Joseph W. Leone United States

Steven P. Leytus United States

Joseph Rahuel Switzerland

Philip G. Penketh United States

Chang H. Park United States

Anzhi Wei

483 ×1.1

205 ×0.9

459 ×2.1

HEMAT

99 ×0.5

208 ×1.2

GENET

Citations per year, relative to Anzhi Wei Anzhi Wei (= 1×) peers Chang H. Park

Countries citing papers authored by Anzhi Wei

Since Specialization

Citations

This map shows the geographic impact of Anzhi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anzhi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anzhi Wei more than expected).

Fields of papers citing papers by Anzhi Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anzhi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anzhi Wei. The network helps show where Anzhi Wei may publish in the future.

Co-authorship network of co-authors of Anzhi Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Anzhi Wei. A scholar is included among the top collaborators of Anzhi Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anzhi Wei. Anzhi Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Xuefang, et al.. (2019). Identification of the candidate genes related to sanshool biosynthesis in Zanthoxylum bungeanum by comparative RNA sequencing analysis. ScienceAsia. 45(5). 425–425.

Wurtz, Nicholas R., Brandon L. Parkhurst, Peter W. Glunz, et al.. (2017). Neutral macrocyclic factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(12). 2650–2654. 5 indexed citations

Corte, James R., Tianan Fang, Donald Pinto, et al.. (2016). Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group. Bioorganic & Medicinal Chemistry. 24(10). 2257–2272. 15 indexed citations

Ladziata, Vladimir, Peter W. Glunz, Yan Zou, et al.. (2016). Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(20). 5051–5057. 6 indexed citations

Richter, Jeremy M., Daniel L. Cheney, Anzhi Wei, et al.. (2016). Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors. ACS Medicinal Chemistry Letters. 8(1). 67–72. 6 indexed citations

Pinto, Donald, Joanne M. Smallheer, James R. Corte, et al.. (2015). Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties. Bioorganic & Medicinal Chemistry Letters. 25(7). 1635–1642. 26 indexed citations

Glunz, Peter W., Xuhong Cheng, Daniel L. Cheney, et al.. (2015). Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(10). 2169–2173. 8 indexed citations

Cheney, Daniel L., Jeffrey M. Bozarth, William J. Metzler, et al.. (2015). Discovery of Novel P1 Groups for Coagulation Factor VIIa Inhibition Using Fragment-Based Screening. Journal of Medicinal Chemistry. 58(6). 2799–2808. 17 indexed citations

Corte, James R., Tianan Fang, Jon J. Hangeland, et al.. (2014). Pyridine and pyridinone-based factor XIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(4). 925–930. 14 indexed citations

10.

Priestley, E. Scott, Jinglan Zhou, Jiacheng Zhou, et al.. (2013). Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(8). 2432–2435. 23 indexed citations

11.

Zhang, Xiaojun, Peter W. Glunz, Wen Jiang, et al.. (2013). Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(6). 1604–1607. 7 indexed citations

12.

Sutton, James, Gregory S. Bisacchi, Bruce L. Jacobson, et al.. (2013). Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold. Bioorganic & Medicinal Chemistry Letters. 23(18). 5239–5243. 12 indexed citations

13.

Glunz, Peter W., Xiaojun Zhang, Yan Zou, et al.. (2013). Nonbenzamidine acylsulfonamide tissue factor–factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(18). 5244–5248. 13 indexed citations

14.

Zhang, Xiaojun, Peter W. Glunz, Yan Zou, et al.. (2013). Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors. ACS Medicinal Chemistry Letters. 5(2). 188–192. 15 indexed citations

15.

Wei, Anzhi, Angela Smallwood, Richard Alexander, et al.. (1999). Crystallization and preliminary X-ray diffraction data of the complex of recombinant tick anticoagulant peptide (rTAP) and bovine factor Xa. Acta Crystallographica Section D Biological Crystallography. 55(4). 862–864. 2 indexed citations

16.

Wei, Anzhi, et al.. (1998). Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. Journal of Molecular Biology. 283(1). 147–154. 69 indexed citations

17.

Wei, Anzhi, Harvey Rubin, Barry S. Cooperman, & David W. Christianson. (1994). Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nature Structural & Molecular Biology. 1(4). 251–258. 147 indexed citations

18.

Wei, Anzhi, et al.. (1993). Crystallization and Atomic Resolution X-Ray Diffraction Analysis of Antichymotrypsin Variants. Biochemical and Biophysical Research Communications. 196(2). 752–757. 2 indexed citations

19.

Wei, Anzhi, Harvey Rubin, Barry S. Cooperman, Norman M. Schechter, & David W. Christianson. (1992). Crystallization, activity assay and preliminary X-ray diffraction analysis of the uncleaved form of the serpin antichymotrypsin. Journal of Molecular Biology. 226(1). 273–276. 6 indexed citations

20.

Wei, Anzhi, et al.. (1990). Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. Biochemistry. 29(33). 7600–7607. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact